CGCN GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVE CLARK | — |
| JAY CRANFORD | — |
| SAM GEDULDIG | — |
| SUSAN GRIFFITHS | — |
| JILL HAMAKER | — |
| AMBER KIRCHHOEFER | — |
| MARTHA BEATRICE MILLER | — |
| MIKE NIELSEN | — |
| ALEX RENJEL | — |
| SCOTT RIPLINGER | — |
| JA'RON SMITH New | — |
| JOHN STIPICEVIC | — |
Homeland Security HOM
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVE CLARK | — |
| JAY CRANFORD | — |
| SAM GEDULDIG | — |
| SUSAN GRIFFITHS | — |
| JILL HAMAKER | — |
| AMBER KIRCHHOEFER | — |
| MARTHA BEATRICE MILLER | — |
| MIKE NIELSEN | — |
| ALEX RENJEL | — |
| SCOTT RIPLINGER | — |
| JA'RON SMITH New | — |
| JOHN STIPICEVIC | — |
Budget/Appropriations BUD
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVE CLARK | — |
| JAY CRANFORD | — |
| SAM GEDULDIG | — |
| SUSAN GRIFFITHS | — |
| JILL HAMAKER | — |
| AMBER KIRCHHOEFER | — |
| MARTHA BEATRICE MILLER | — |
| MIKE NIELSEN | — |
| ALEX RENJEL | — |
| SCOTT RIPLINGER | — |
| JA'RON SMITH New | — |
| JOHN STIPICEVIC | — |
Disaster Planning/Emergencies DIS
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVE CLARK | — |
| JAY CRANFORD | — |
| SAM GEDULDIG | — |
| SUSAN GRIFFITHS | — |
| JILL HAMAKER | — |
| AMBER KIRCHHOEFER | — |
| MARTHA BEATRICE MILLER | — |
| MIKE NIELSEN | — |
| ALEX RENJEL | — |
| SCOTT RIPLINGER | — |
| JA'RON SMITH New | — |
| JOHN STIPICEVIC | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.